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Background: Little is known about the microcirculatory alterations in patients with chronic 
mesenteric ischemia (CMI). We hypothesized that patients with CMI have an impaired microcir-
culatory function and show an oral microcirculatory response after caloric challenge compared 
to healthy controls.
Methods: All patients and controls received the standard workup for CMI. Sublingual micro-
circulation was evaluated before (T0) and 20 minutes after (T1) feeding. The total vessel density 
(TVD; mm/mm2), perfused vessel density (PVD; mm/mm2), proportion of perfused vessels 
(PPV; %) and microvascular flow index (MFI; AU) were assessed.
Results: We included 12 patients (63.2 years [IQR 48.8–70.4 years], 67% males) and 12 
controls (32.7 years [IQR 27.7–38.1 years], 42% males). At baseline, patients with CMI had a 
decreased PPV of the sublingual small vessels (median 84.8% vs 95.7%, P=0.006), PPV of all 
vessels (PPV median 85.4% vs 95.3%, P=0.007) and microvascular flow index of all vessels 
(MFIa; median 3.00 vs 2.80, P=0.039) compared to healthy controls. After caloric challenge, 
PVD increased significantly in both small vessels (perfused vessel density of the small vessels 
[PVDs]) and all vessels (perfused vessel density of all vessels [PVDa]; PVDs [T0]) median 
16.3 [IQR 13.3–22.1] vs [T1] median 19.9 [IQR 14.2–26.2], P=0.008; PVDa [T0] median 19.1 
[IQR 16.2–23.6] vs [T1] median 22.2 [IQR 16.5–28.9], P=0.02; proportion of perfused vessels 
of the small vessels (PPVs; [T0] median 84.8% [IQR 75.3–90.4] vs [T1] median 91.0% [IQR 
80.1–93.8], P=0.010). In contrast, no significant changes in microcirculatory parameters were 
observed after caloric challenge in healthy controls.
Conclusion: Patients with CMI have an impaired sublingual microcirculation at baseline and 
show a significant response in the sublingual microcirculation after caloric challenge, whereas 
healthy controls have a normal microcirculation at baseline and show no reactive response upon 
a caloric challenge as seen in CMI patients. Sublingual microcirculation visualization may offer 
a rapid noninvasive method to identify patients at risk for having CMI.
Keywords: chronic mesenteric ischemia, ischemia, sublingual microcirculation, Cytocam-IDF, 
diagnosis
Introduction
Chronic mesenteric ischemia (CMI) results from insufficient blood supply to the 
stomach, small intestine and colon, leading to decreased mucosal perfusion and 
oxygenation.1 In most cases, CMI is caused by stenosis of the supplying arteries 
due to atherosclerosis. Chronic heart failure and pulmonary conditions can further 
contribute to or predominate CMI (so-called nonocclusive mesenteric ischemia 
[NOMI]).2
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Patients with CMI have insuff icient postprandial 
increase in the splanchnic blood flow after ingesting 
food,which causes a misbalance between oxygen delivery 
and metabolic demand and often results in postprandial 
discomfort.3 Until recently, it was thought that CMI could 
only occur in the presence of at least two occluded mes-
enteric arteries, but studies have shown that a significant 
stenosis of a single artery can also lead to clinically relevant 
gastrointestinal ischemia.4,5 In patients with single-vessel 
CMI, the symptoms are thought to be related to insufficient 
collateral circulation.2 Another underlying cause might be 
that patients with CMI have microcirculatory alterations 
associated with systemic disorders of the circulatory sys-
tem. The majority of patients with CMI have hypertension, 
diabetes and other cardiovascular conditions.6 Therefore, 
microvascular pathology in this patient group is very likely, 
which might explain why single-vessel stenosis can lead to 
clinical symptoms even in the presence of seemingly suf-
ficient collateral circulation.
However, the microcirculation has not been studied in 
patients with CMI. In patients with hemodynamic shock and 
acute gastrointestinal ischemia, a correlation between intesti-
nal ischemia and sublingual microcirculatory alterations has 
been observed during investigations of buccal, sublingual 
and intestinal mucosa.7–10 Another study reported decreased 
microvessel density and erythrocyte velocity in both the 
sublingual and gut regions.11 Sublingual capillary perfusion 
correlated with the hypoxic state of the gastric mucosa in 
these patients.9,12,13 The sublingual PCO
2
 in patients with sep-
tic shock paralleled gastric PCO
2
 as measured using gastric 
tonometry.14 Similarly, in elective stoma surgery complicated 
by sepsis, sublingual and ileal microcirculatory alterations 
were correlated.
To our knowledge, no study has investigated the relation-
ship between sublingual microcirculation and hemodynamic 
changes in patients with CMI. Based on the findings in 
patients with acute ischemia, we formulated the hypothesis 
that 1) patients show an oral microcirculatory response after 
caloric challenge different from that of healthy individuals 
and 2) patients with CMI have impaired microcirculatory 
function compared with that of healthy individuals.
Methods
study population
Patients with confirmed CMI were enrolled between Septem-
ber 2014 and August 2015. The current established approach 
for diagnosing CMI is based on three main components. 
The first component includes assessment of medical history, 
clinical symptoms and physical examination. The second 
component concerns radiological imaging of the mesenteric 
arteries, and the third component aims at detection of mucosal 
ischemia by means of a functional test. All patients and pro-
cedures are discussed by a dedicated multidisciplinary team 
consisting of a vascular surgeon, intervention radiologist and 
gastroenterologist, all specialized in CMI, leading to a final 
expert-based consensus diagnosis.
The diagnosis of CMI is established if a patient fulfills 
two of the three following criteria:15
1. Distinctive clinical presentation including presence of 
postprandial pain and otherwise unexplained weight loss 
of >5% of the normal body weight.
2. Significant stenosis of >70% of at least one of the mes-
enteric arteries demonstrated by radiological evaluation.
3. Mucosal ischemia detected by tonometry or visible light 
spectroscopy (VLS). Mucosal ischemia was defined as 
mucosal oxygen saturation <58%, <62%, or <63% for 
measurements in the duodenum, duodenal bulb and 
antrum of the stomach, respectively, based on previous 
assessments in patients and healthy controls.2,16,17
A definitive diagnosis of CMI is made after persistent relief 
of symptoms on follow-up after treatment, which included 
revascularization in patients with stenotic CMI and vasodila-
tory medication in patients with NOMI.
This is not the ideal gold standard; however, it is currently 
the most reliable way to establish CMI. For single-vessel 
disease, all three criteria should apply.2,16,17
Nonsmoking healthy subjects with patent gastrointestinal 
arteries as determined by abdominal duplex ultrasound, no 
gastrointestinal complaints and unremarkable medical his-
tory were asked to participate in our study on a voluntary 
basis.
All patients provided written informed consent prior 
to participation to the study. Approval for the study was 
obtained from the institutional review board of the Erasmus 
MC University Medical Center Rotterdam, the Netherlands 
(MEC number 2013-003).
assessment of microcirculation
We measured sublingual microcirculation according to the 
latest consensus guidelines using the Cytocam-IDF device 
before (T0) and 20 minutes after (T1) enteral feeding.18 
Patients and healthy controls received enteral feeding 
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through an endoscopically placed feeding tube in the 
antrum. Through the feeding tube, patients were given 300 
mL of compound liquid food (Nutrison Energy®; Nutricia 
Advanced Medical Nutrition, Zoetermeer, the Netherlands), 
a solution of carbohydrates, protein and fat with a low vol-
ume and a high caloric content (450 kcal). At each time point, 
microcirculation was assessed at three different sublingual 
mucosal locations for a minimum of 4 seconds per sequence 
as previously described.19 The locations concerned the 
sublingual mucosal tissue surface at the floor of the mouth 
adjacent to the lingual frenulum. Great care was taken to 
clear saliva before image acquisition. Film sequences were 
repeatedly taken until three sequences of good quality were 
obtained. The quality of the images was assessed using the 
Massey score for microcirculation image quality.20 Video-
image analysis was performed blindly by one independent 
researcher (MSTD) according to protocol using Automated 
Vascular Analysis (AVA) 3.0.21 The following parameters 
were obtained for small vessels and all vessels: total vessel 
density (TVD; mm/mm2), perfused vessel density (PVD; 
mm/mm2), proportion of perfused vessels (PPV; %) and 
microvascular flow index (MFI; AU). The definition for 
PVD is the total length (mm) of perfused vessels divided 
by the total mucosal surface, and PPV is defined as the 
proportion of perfused vessels divided by the total vessels 
on the recorded surface.
statistical analyses
Baseline characteristics were calculated using descriptive 
statistics. Data were expressed as median and IQR or count 
and percentage (%), as appropriate. A Wilcoxon signed-rank 
test was performed to study the differences between base-
line and postprandial parameters of the microcirculation in 
CMI patients and healthy controls. Statistical analysis was 
performed using SPSS 21.0 program (SPSS Inc., Chicago, 
IL, USA). A two-sided P-value of <0.050 was considered 
as significant.
Results
Patient characteristics
During the study period, 49 consecutive patients with clini-
cal suspicion of CMI were eligible for the study. Informed 
consent was received from 31 (63%) patients. Reasons for 
nonparticipation were mostly poor condition of the patient 
or anxiety regarding undergoing multiple tests. Three (6%) 
patients failed to complete this workup, leaving a total 
of 28 (57%) participants in the study. The results of the 
diagnostic workup of these 28 patients were discussed by 
a  multidisciplinary expert panel. A consensus diagnosis of 
CMI was made in 14 (50%) patients, whereas CGI was ruled 
out in 14 (50%) patients.
During follow-up (median 3.0 [IQR 1–6] months), two 
patients were lost to follow-up, leaving a total of 12 patients 
with CMI (11 patients with occlusive CMI and one patient 
with NOMI). For the characteristics of patients and controls, 
see Table 1.
Table 1 Baseline characteristics of CMi patients and controls
CMI (n=12) Controls (n=12)
Agea 63.2 (48.8–70.4) 32.7 (27.7–38.1)
Gender
Male
Female
8 (67)
4 (33)
5 (42)
7 (58)
BMI (kg/m2)a 24.2 (21.5–28.3) 22.3 (20.4–24.8)
Symptomatology
abdominal pain
Postprandial pain
Exercise-induced pain
Weight loss
Weight loss (kg/months)a
Diarrhea
nausea
Duration of symptoms (months)a
10 (83)
9 (75)
4 (33)
7 (58)
2.0 (1.1–3.0)
2 (17)
5 (42)
10.0 (6.0–21.0)
0
0
0
0
0
0
0
0
Cardiovascular comorbidity
history of CVD
CaD alone
PaD alone
Both
hypertension
DM type ii
hypercholesterolemia
Family history of CVD
8 (67)
0 (0)
4 (33)
4 (33)
7 (58)
3 (25)
6 (50)
5 (42)
0
0
0
0
0
0
0
0
smokingb
Current
Former
Pack yearsa
alcohol use
alcohol (U/day)c
10 (83)
6 (50)
4 (33)
162 (0–356)
6 (50)
0 (0–1.8)
4 (40)
1 (8)
3 (25)
0
8 (67)
0.6 (0–1.0)
Mesenteric artery stenosisd
no stenosis
single artery stenosis
Multi artery stenosis
1 (8)
4 (33)
7 (58)
0
0
0
VLS measurement
antruma 58.5 (53.5–59.0) 61.5 (60.0–63.0)
Duodenal bulba 53.0 (48.8–54.0) 59.0 (54.0–63.8)
Descending duodenuma 49.5 (45.3–52.8) 51.5 (47.5–56.0)
Notes: Values represent the number and percentage of patients unless otherwise 
specified. aMedian, iQr. bincludes current and former smokers. cMedian, range. 
dStenosis of the mesenteric arteries is defined as >70% lumen reduction on CTa 
or Mra.
Abbreviations: BMi, body max index; CaD, cardial arterial disease; CMi, chronic 
mesenteric ischemia; CTa, computed tomography angiography; CVD, cardiovascular 
disease; DM, diabetes mellitus; Mra, magnetic resonance angiography; PaD, 
peripheral arterial disease; Vls, visible light spectroscopy.
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sublingual microcirculation
A snapshot of a recorded image of the sublingual microcir-
culation of a healthy volunteer obtained during the study is 
shown in Figure 1. Absolute data and ranges for the micro-
vascular variables of all patients and controls are provided 
in Table 2. Compared to the baseline (T0), perfused vessel 
density of the small vessels (PVDs) and perfused vessel den-
sity of all vessels (PVDa) significantly increased in patients 
with CMI after caloric challenge (T1; PVDs median 16.3 
mm/mm2 [IQR 13.3–22.1 mm/mm2] vs 19.9 mm/mm2 [IQR 
14.2–26.2 mm/mm2], P=0.008; PVDa median 19.1 mm/mm2 
[IQR 16.2–23.6 mm/mm2] vs 22.2 mm/mm2 [IQR 16.5–28.9 
mm/mm2], P=0.020; Table 3 and Figure 2). Furthermore, there 
was a significant increase in the proportion of perfused vessels 
of the small vessels (PPVs) between baseline (T0) and after 
caloric challenge (T1; median 84.8% [IQR 75.3%–90.4%] vs 
91.0% [IQR 80.1%–93.8%], P=0.010). This did not pertain to 
the proportion of perfused vessels of all vessels (PPVa; median 
85.4% [IQR 79.8%–91.5%] vs 90.4% [IQR 81.4–94.4], 
P=0.050; Figure 3). In addition, there was a nonsignificant 
increase in total vessel density of the small vessels (TVDs) 
after caloric challenge (median 20.8 mm/mm2 [IQR 17.6–23.8 
mm/mm2] vs 22.4 mm/mm2 [IQR 17.8–32.2 mm/mm2], 
P=0.090). In contrast, there was no significant difference 
in microcirculation between the values at baseline and after 
caloric challenge in healthy volunteers (Figure 4 and Table 3).
At baseline (T0), patients with CMI had a decreased 
PPVs (median 84.8% vs 95.7%, P=0.006), PPVa (median 
85.4% vs 95.3%, P=0.007; Figure 4) and microvascular flow 
index of all vessels (MFIa; median 2.8 vs 3.0, P=0.039) com-
pared with those of healthy controls. After caloric challenge 
(T1), patients with CGI had a decreased PPVa compared 
Figure 1 recorded image of the sublingual microcirculation of a healthy volunteer 
obtained during the study.
200 m
to the healthy controls (median 90.4% vs 94.8%, P=0.039) 
and MFIa (median 2.9 vs 3.0, P=0.014). The difference in 
sublingual microcirculatory parameters between patients 
and healthy controls is shown in Table 3. Video clips of an 
example of sublingual microcirculation of a healthy indi-
vidual and of CMI patients can be found in Videos S1–S4.
Discussion
The main findings of our study were that: 1) at baseline, 
patients with CMI have a significantly lower PPV and a lower 
microcirculatory flow index than those of healthy controls; 2) 
increased metabolic demand induced by food intake caused 
in CMI patients an increase in PVD and in PPV, whereas 
this did not occur in the healthy controls; and 3) despite the 
increase in PVD and PPV of the CMI patients, levels did not 
reach the normal levels of the healthy controls. These latter 
findings are consistent with the idea that the compromised 
microcirculation of CMI patients requires recruitment of the 
microcirculation to meet the metabolic demand imposed by 
food intake, but that this does not occur in health where there 
is sufficient microcirculatory reserve to meet such a demand.
Previous studies in patients with CMI focused on macro-
vascular alterations.22–24 Patients with CMI have an impaired 
postprandial increase in the splanchnic blood flow, leading to 
insufficient oxygen delivery to meet the metabolic demand 
of the gastrointestinal tract.3 Another underlying cause might 
be that patients with CMI have microcirculatory alterations 
associated with systemic disorders of the circulatory system, 
which may also be attributed to the presence of clinical symp-
toms.6 Systemic microvascular pathology in this patient group 
is very likely, given the high association with cardiovascular 
conditions. This might explain why single-vessel stenosis can 
lead to clinical symptoms even in the presence of sufficient 
collateral circulation. We therefore hypothesized that patients 
with CMI may also exhibit microcirculatory alterations rela-
tive to healthy controls. We also hypothesized that sublingual 
microcirculation is responsive to enteral caloric challenges 
and that, based on preexisting microcirculatory alterations 
in CMI, microcirculation provides a way to indirectly assess 
intestinal microcirculation.
Our study shows that patients with CMI experience a 
significant need to recruit the microcirculation to meet the 
metabolic stress induced by the caloric challenge and thus 
have a response to the ingestion of food of highly caloric food. 
However, this hyperemic response to the ingestion of food 
was not seen in the healthy volunteers. Therefore, it seems 
that patients with CMI have a poor microcirculation to begin 
with, despite the increase in microcirculatory parameters after 
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Table 2 individual data of sublingual microcirculation of patients with CMi and healthy controls
Patient Time 
pointa
Parameters
TVDs  
(mm/mm2)
TVDa  
(mm/mm2)
PVDs  
(mm/mm2)
PVDa  
(mm/mm2)
PPVs  
(%)
PPVa  
(%)
MFIs 
(AU)
MFIa 
(AU)
1 0 19.13 24.22 17.19 22.25 90.50 92.27 2.83 2.94
1 18.76 21.81 16.29 19.24 86.48 87.66 3.00 2.84
2 0 15.36 18.00 13.58 16.17 87.58 89.20 3.00 2.61
1 13.87 15.01 13.32 14.46 95.97 96.17 3.00 2.90
3 0 17.64 21.08 13.27 16.71 75.34 79.35 2.67 2.56
1 17.51 21.93 14.33 17.95 82.80 83.28 2.50 2.80
4 0 23.95 25.18 21.78 23.01 91.44 91.78 3.00 2.97
1 34.90 38.03 32.31 35.44 92.92 93.46 3.00 3.00
5 0 23.45 25.04 22.25 23.84 94.80 95.20 3.00 3.00
1 25.42 28.44 24.96 27.98 98.05 98.36 3.00 3.00
6 0 20.54 24.13 10.82 13.43 52.52 55.79 1.58 1.94
1 19.90 23.94 12.58 16.21 62.63 66.41 2.33 2.58
7 0 21.11 23.87 15.35 17.00 73.64 72.98 2.75 2.50
1 16.50 18.31 15.47 17.26 92.81 93.74 3.00 2.94
8 0 31.68 34.26 28.80 31.37 89.98 90.70 3.00 3.00
1 34.45 35.76 31.09 32.20 90.40 90.08 3.00 2.93
9 0 11.88 15.65 8.98 12.75 75.25 81.11 2.83 2.70
1 18.52 20.77 14.21 16.10 77.20 78.16 2.89 2.49
10 0 23.66 25.68 19.24 21.25 81.95 83.09 2.67 2.89
1 27.78 27.78 25.43 25.24 91.57 90.79 3.00 2.89
11 0 28.70 31.06 22.72 25.08 79.47 81.06 2.75 2.75
1 33.67 36.33 26.51 29.17 79.22 80.79 2.58 2.82
12 0 17.56 19.01 15.12 16.26 88.39 87.66 3.00 2.85
1 24.85 27.32 23.42 25.88 94.11 94.62 3.00 3.00
Control
1 0 33.52 34.51 32.70 33.68 97.39 97.46 3 3
1 27.14 28.13 25.32 26.30 92.41 92.68 3 3
2 0 23.11 25.21 20.52 22.61 86.80 88.16 3 2.75
1 20.27 22.52 19.47 21.72 95.39 96.05 3 3
3 0 24.46 25.55 23.49 24.58 95.29 94.34 3 3
1 29.36 31.45 28.23 30.32 96.30 96.51 3 3
4 0 16.38 16.88 16.34 16.84 99.77 99.78 3 3
1 17.01 17.74 15.49 16.22 91.21 91.94 2.83 2.78
5 0 20.58 22.81 13.00 14.58 61.76 62.43 2.75 2.47
1 19.70 23.01 16.92 20.24 82.52 84.60 2.75 2.86
6 0 16.33 19.05 13.88 17.66 89.69 91.99 2.83 2.74
1 24.56 26.22 24.56 26.38 100.00 100.00 3 3
7 0 20.94 22.54 19.04 20.35 90.96 90.21 3 3
1 23.87 24.20 22.14 22.47 92.68 92.78 3 3.03
8 0 19.63 20.32 19.54 20.23 99.60 99.60 3 3
1 16.85 19.73 16.59 19.28 98.18 97.66 3.13 3
9 0 24.50 26.35 22.19 24.04 90.81 91.21 3 3
1 23.32 23.32 19.85 23.09 98.91 99.03 3 3
10 0 23.36 25.88 23.28 25.81 99.68 99.70 3 3
1 19.56 22.78 18.28 21.41 92.66 93.57 3 3
11 0 25.15 25.88 24.14 24.88 96.11 96.20 3 2.93
1 26.13 29.46 24.34 27.67 90.78 92.32 3 3
12 0 23.48 25.33 23.06 24.87 97.79 97.73 3 3
1 23.26 25.90 23.14 25.59 99.46 98.83 3 3
Notes: aTime point 0 is the baseline before caloric challenge, and time point 1 is after caloric challenge. bP<0.050 is considered as significant.
Abbreviations: CMI, chronic mesenteric ischemia; MFIa, microvascular flow index of all vessels; MFIs, microvascular flow index of the small vessels; PPVa, proportion of 
perfused vessels of all vessels; PPVs, proportion of perfused vessels of the small vessels; PVDa, perfused vessel density of all vessels; PVDs, perfused vessel density of the small 
vessels; TVDa, total vessel density of all vessels; TVDs, total vessel density of the small vessels.
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a caloric challenge to compensate for the microcirculatory 
shortcoming. In contrast, it seems that healthy controls begin 
with normal microcirculation; therefore, no compensatory 
microcirculatory mechanism is initiated to ingest food. 
From this reasoning, it follows that microcirculation before 
Table 3 Difference in sublingual microcirculatory parameters before and after caloric challenge
Parameters Time pointa Patients (n=12) Controls (n=12)
Median (IQR) P-valueb Median (IQR) P-valueb
TVDs (mm/mm2) 0 20.8 (17.6–23.8) 0.090 23.2 (20.1–24.5) 0.810
1 22.4 (17.8–32.2) 23.3 (19.6–25.3)
TVDa (mm/mm2) 0 24.2 (19.5–25.6) 0.180 25.3 (21.4–25.9) 0.750
1 25.6 (21.0–33.9) 23.8 (22.7–27.2)
PVDs (mm/mm2) 0 16.3 (13.3–22.1) 0.008 21.4 (17.7–23.4) 1.00
1 19.9 (14.2–26.2) 21.0 (17.6–24.5)
PVDa (mm/mm2) 0 19.1 (16.2–23.6) 0.020 23.3 (18.9–24.9) 0.580
1 22.2 (16.5–28.9) 22.8 (20.8–26.3)
PPVs (%) 0 84.8 (75.3–90.4) 0.010 95.7 (90.3–98.7) 0.430
1 91.0 (80.1–93.8) 94.0 (91.8–98.5)
PPVa (%) 0 85.4 (79.8–91.5) 0.050 95.3 (90.7–98.7) 0.430
1 90.4 (81.4–94.4) 94.8 (92.5–98.2)
MFis (aU) 0 2.8 (2.7–3.0) 0.170 3.0 (3.0–3.0) 0.790
1 3.0 (2.7–3.0) 3.0 (3.0–3.0)
MFia (aU) 0 2.8 (2.6–3.0) 0.140 3.0 (2.8–3.0) 0.120
1 2.9 (2.8–3.0) 3.0 (3.0–3.0)
Notes: aTime point 0 is at baseline before caloric challenge, and time point 1 is after caloric challenge. bP<0.050 is considered as significant.
Abbreviations: MFIa, microvascular flow index of all vessels; MFIs, microvascular flow index of the small vessels; PPVa, proportion of perfused vessels of all vessels; PPVs, 
proportion of perfused vessels of the small vessels; PVDa, perfused vessel density of all vessels; PVDs, perfused vessel density of the small vessels; TVDa, total vessel density 
of all vessels; TVDs, total vessel density of the small vessels.
Figure 2 PVDs (mm/mm2) of all patients with CMi at baseline (T0) and after caloric 
challenge (T1).
Note: Boxes represent medians with iQrs, whiskers extend to the most and least 
extreme scores and * denotes <0.050.
Abbreviations: CMi, chronic mesenteric ischemia; PVDs, perfused vessel density 
of the small vessels.
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Figure 3 PPVs (mm/mm2) of all patients with CMi at baseline (T0) and after caloric 
challenge (T1).
Note: Boxes represent medians with iQr, whiskers extent to the most and least 
extreme scores and * denotes <0.050.
Abbreviations: CMi, chronic mesenteric ischemia; PPVs, proportion of perfused 
vessels of the small vessels.
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food exposure in CMI patients is lower than that in healthy 
individuals and that the compensatory increase after food 
 challenge does not reach normal levels. Further studies 
including more patients and healthy controls using the cur-
rent protocol are needed to further investigate this matter.
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Our study has several limitations. The first limitation 
is the diagnosis of CMI. The diagnosis of CMI is a clini-
cal challenge. This is first because patients with CMI may 
present with a variety of symptoms. Furthermore, there is 
no single, accurate test to diagnose or exclude CMI. The role 
of clinical symptoms alone in the diagnosis of CMI is lim-
ited.22,25 The combination of postprandial pain, weight loss 
and presence of an abdominal bruit is known as the classical 
triad of CGI. Indeed, our study could have benefitted from 
a careful assessment of clinical symptoms related to CMI 
following our challenge with a meal and measurement of 
the microcirculatory response, and this omission could be 
considered as a limitation of our study. This is however only 
present in 16%–21% of patients and has limited predictive 
value for diagnosing CGI.22,26,27 This supports the current 
diagnostic approach that combines assessment of clinical 
symptoms with radiological imaging of the gastrointestinal 
arteries and functional testing by tonometry or VLS.2 This 
is not the ideal gold standard; however, it is currently the 
most reliable way to establish CMI. Patients with CMI and 
the healthy controls were under conscious sedation with 
intravenous midazolam and fentanyl at the time of the 
second sublingual microcirculatory measurements after 
caloric  challenge but not during the baseline sublingual 
measurements. A recent study showed that the sublingual 
microcirculation in patients with shock was greater after 
the infusion of midazolam.28 In this study, the PPV was 
Figure 4 PPVs (mm/mm2) of patients with CMi and healthy controls at baseline (T0) 
and after caloric challenge (T1).
Note: Boxes represent medians with iQr, whiskers extend to the most and least 
extreme scores and * denotes <0.050.
Abbreviations: CMi, chronic mesenteric ischemia; PPVs, proportion of perfused 
vessels of the small vessels.
Healthy controls
*
* *
Patients with CMI
PP
va
 (m
m
/m
m
2 )
100
90
80
60
50
Time point
Ba
se
lin
e
Aft
er 
ca
lor
ic 
ch
all
an
ge
significantly greater after the infusion of midazolam (PPV 
median 96.4% [IQR 93.7–97.6] vs 92.7% [IQR 88.3–94.7], 
P<0.005). Therefore, one could hypothesize that the hyper-
emic response in our patients after caloric challenge might be 
partly due to the effect of midazolam. This phenomenon was 
not observed in the healthy controls. Therefore, the effect of 
conscious sedation seems limited. Furthermore, the small 
sample size of patients and controls could be affected by 
confounders. The major four confounders in this study are 
cardiovascular comorbidities, age, smoking and diabetes. It 
is suggested that a possible confounder in the results could 
be the difference in age between the control group (mean age 
32 years) and CMI patients (mean age 63 years). However, a 
recent study by Kanoore Edul et al29 showed that that there 
is no relation between age and sublingual microvascular 
vascular density. In addition, as one-third of the patients 
have generalized arterial atherosclerosis, this could affect the 
sublingual microcirculation. However, to find patients with 
CMI without any history of CVD would however be very 
difficult and would decrease the sample size in our study. Yet 
in our study, one-third of our patients had no cardiovascular 
morbidity at all. Additionally, half of the patients are current 
smokers, which could induce microcirculatory changes in 
the mouth as suggested by Morozumi et al.30 However, there 
are a number of critical comments that can be made about 
this study. The study concerns the effects of smoking cessa-
tion on flow (eg, most likely simply related to the amount of 
circulating carbon monoxide). The first is that a similar study 
had been carried out using the same technique and location 
and it was found the opposite in that there was no differ-
ence in gingival microcirculatory flow between smokers and 
nonsmokers.31 It should also be pointed out that the laser 
Doppler technique used in these studies has known short 
comings in assessing the microcirculation. This includes that 
it measures an unspecific physiological compartment and is 
a nonquantitative measurement expressed in arbitrary units. 
It does not measure the microcirculatory vessel density in a 
quantitative manner (eg, mm/mm2) as measured by handheld 
video microscopy where there is direct observation of the 
microcirculation. We investigated the effect of smoking 
using handheld video microscopy in a previous study in 
the same location as the study by Morozumi et al (the gin-
giva), and in contrast to their study, we found no effects of 
smoking on the gingival microcirculation.32 Another study 
looking at the sublingual microcirculation using handheld 
video microscopy confirmed these findings where no effect 
was found on sublingual microcirculation.29 This latter study 
also showed that smoking and age do not affect the micro-
circulation.29 However, it did show microcirculatory changes 
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in patients with hypertension compared to patients without 
hypertension. However, these changes were only seen for 
TVD. If we compare the PPVs in the CMI patients with this 
study, there is a difference of 85.4% vs 100%. We cannot 
compare the other microcirculatory parameters as we used 
the IDF device and the study of Kanoore et al used the stream 
dark field device. Indeed, diabetes mellitus (DM) could have 
affected the microcirculation; however, only 25% of the 
CMI patients had DM type 2, and therefore, we do think the 
influence is minimal on the microcirculation in our study. 
All these confounders can affect the microcirculatory dif-
ferences between the patients and healthy controls; however, 
this does not affect the microcirculatory differences within 
a patient. Future research should focus on better matching 
of patients and controls by including controls known with 
DM and a smoking history to set the correct baseline from 
which a comparison can be established, thereby eliminating 
these confounders. A different type of confounder could have 
been the physiological metabolic response to a meal in the 
maxillomandibular musculature in the form of a reactive 
hypereamic response following ingestion of food. Indeed, 
a delayed reactive hyperemic response has been measured 
in the masseter in volunteers following clenching.33 How-
ever, this hyperemic response was found to be over within 2 
minutes, whereas our microcirculatory measurements were 
performed 20 minutes after the administration of the meal, 
so we do not think this response could be a confounder. In 
addition, we administered the meal not orally but instead 
by a feeding tube placed in the antrum of the stomach. 
Finally, this study focuses more on the physiology of the 
microcirculation before and after a meal in CMI patients; 
therefore, no definite conclusions should be drawn from the 
differences with the healthy controls as no other studies have 
been performed on microcirculation after a meal. More and 
larger studies are needed to confirm the findings of our study.
To our knowledge, this is the first study to investigate the 
sublingual microcirculation in patients with CMI. Patients 
with CMI have less perfused capillaries in the sublingual 
microcirculation before food exposure compared with that 
of healthy controls and that the compensatory increase after 
food challenge in these patients does not reach normal lev-
els. Furthermore, we found patients with CMI experience 
a significant increase in PVD and PPV after stimulation 
with food and therefore have a hyperemic response to the 
ingestion of food. However, this response is not sufficient 
to increase the microcirculation of CMI patients to the 
microcirculatory state of healthy volunteers with or without 
caloric challenge.
This study provides us additional insight into the relation-
ship between the microcirculation and hemodynamic changes 
in the gastrointestinal tract. These findings may lead to the 
development of diagnostic methodology to identify patients 
at risk of having CMI. To establish such a clinical screening 
methodology for the identification of patients at risk for CMI, 
larger studies focusing on the sensitivity and specificity of 
measured alterations in the sublingual microcirculation would 
have to be undertaken.
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Supplementary materials
Video S1 Capturing sublingual microcirculation of a patient with chronic mesenteric 
ischemia before caloric challenge.
Video S2 Capturing sublingual microcirculation of a patient with chronic mesenteric 
ischemia after caloric challenge.
Video S3 Capturing the sublingual microcirculation of a healthy control before 
caloric challenge.
Video S4 Capturing the sublingual microcirculation of a healthy control after 
caloric challenge.
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